In this issue
Weight Loss Medications and Heart Disease Risk: What Do We Know?
Diabetes and obesity are two conditions that can raise the risk for both heart disease and blood clots. Now, a new class of medications called glucagon-like peptide-1 receptor agonists (aka GLP-1s ) has been getting a lot of...
Read
Blood Clot Risk in the Transgender Community: A Message from Our Patient Advocates!
This Pride Month, NATF is proud to update our readers about an initiative that we featured in this newsletter one year ago: Assessing and Addressing the Risk of Blood Clots Across the Spectrum of Gender-Affirming Care.
Read
The Beat, in your inbox.
Expert insights, practical tips, and stories from others who are living well with vascular conditions.